Sleep (Hyland’s)


Welcome to the PulseAid listing for the Sleep drug offered from Hyland’s. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hyland’s
NON-PROPRIETARY NAME: HYOSCYAMUS NIGER, STRYCHNOS IGNATII SEED, and POTASSIUM PHOSPHATE, DIBASIC
SUBSTANCE NAME: HYOSCYAMUS NIGER; STRYCHNOS IGNATII SEED; POTASSIUM PHOSPHATE, DIBASIC
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2014-11-05
END MARKETING DATE: 0000-00-00


Sleep HUMAN OTC DRUG Details:

Item DescriptionSleep from Hyland’s
LABELER NAME: Hyland’s
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 3([hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2014-11-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54973-3206_82080ce0-b30b-4dd8-bf0b-536e81c83f61
PRODUCT NDC: 54973-3206
APPLICATION NUMBER:

Other HYOSCYAMUS NIGER; STRYCHNOS IGNATII SEED; POTASSIUM PHOSPHATE, DIBASIC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hyland’sSleep